Jasco Pharmaceuticals to Present its Preclinical PIM Inhibitor Program at the American Association for Cancer Research Annual Meeting

April 1, 2013

Jasco Pharmaceuticals, LLC announced that preclinical data on its PIM inhibitor program would be presented at the American Association for Cancer Research (AACR) Annual Meeting 2013 to be held on April 6-10 in Washington, DC. Click to read the full release.

Jasco Pharmaceuticals Initiates a Collaborative Research Program in Pancreatic Cancer with North Carolina Central University

March 10, 2011

Jasco Pharmaceuticals, LLC has initiated a collaborative research program with North Carolina Central University (NCCU) in Durham, North Carolina, focused on developing therapeutics for pancreatic cancer that function through a Pim kinase mechanism of action. Click to read the full release.

Crown Biosciences Announces Partnership With Jasco Pharmaceuticals to Develop Oncology Programs

December 7, 2010

Crown Bioscience, Inc. announces their partnership with Jasco Pharmaceuticals (Woburn, MA) providing discovery and pre-clinical Cancer Biology services for Jasco’s lead program. Click to read the full release.

Jasco Pharmaceuticals Awarded Grant

November 4, 2010

Jasco Pharmaceuticals, LLC was awarded a grant under the US Government’s Patient Protection and Affordable Care Act (PPACA) of 2010. Click to read the full release.

Innovation in Drug Discovery

July 20, 2009

JascoPharma, LLC moves into their fully customized 2,500 sq. ft. facility in Woburn, MA.